High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis
Hemasphere
.
2022 Oct 26;6(11):e793.
doi: 10.1097/HS9.0000000000000793.
eCollection 2022 Nov.
Authors
Elsemieke Te Linde
1
,
Laura J E Boots
1
,
Laura G M Daenen
2
,
Moniek A de Witte
2
,
Anke H W Bruns
1
2
Affiliations
1
Department of Infectious Diseases, University Medical Center Utrecht, the Netherlands.
2
Department of Hematology, University Medical Center Utrecht, the Netherlands.
PMID:
36325270
PMCID:
PMC9619234
DOI:
10.1097/HS9.0000000000000793
No abstract available